ArticleCancer management and research2011

Dose study of the multikinase inhibitor, LY2457546, in patients with relapsed acute myeloid leukemia to assess safety, pharmacokinetics, and pharmacodynamics.

Volker Wacheck et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.